Brief: Anika Therapeutics Q4 Revenue USD 42.971 Million

Anika Therapeutics

13/03/2024 20:06

Mar 13 (Reuters) - Anika Therapeutics Q4 net income USD -63 million.
* Q4 pretax profit USD -63.204 million
* Q4 income from operations USD -63.781 million
* Q4 gross profit USD 26.329 million